These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 28729483)

  • 41. Molecular and Cellular Changes During Cancer Progression Resulting From Genetic and Epigenetic Alterations.
    Pruitt K
    Prog Mol Biol Transl Sci; 2016; 144():3-47. PubMed ID: 27865461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of epigenetics in environmental and occupational carcinogenesis.
    Ziech D; Franco R; Pappa A; Malamou-Mitsi V; Georgakila S; Georgakilas AG; Panayiotidis MI
    Chem Biol Interact; 2010 Nov; 188(2):340-9. PubMed ID: 20599843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer as a manifestation of aberrant chromatin structure.
    Brock MV; Herman JG; Baylin SB
    Cancer J; 2007; 13(1):3-8. PubMed ID: 17464240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic analysis in the search for tumor suppressor genes.
    Han ZG
    Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
    [No Abstract]   [Full Text] [Related]  

  • 47. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
    D'Alessio AC; Szyf M
    Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functions, aberrations, and advances for chromatin modulation in cancer.
    Conte M; Altucci L
    Cancer Treat Res; 2014; 159():227-39. PubMed ID: 24114483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
    Semi K; Yamada Y
    Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetics as a mediator of plasticity in cancer.
    Feinberg AP; Levchenko A
    Science; 2023 Feb; 379(6632):eaaw3835. PubMed ID: 36758093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyploidy and Myc Proto-Oncogenes Promote Stress Adaptation via Epigenetic Plasticity and Gene Regulatory Network Rewiring.
    Anatskaya OV; Vinogradov AE
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diverse epigenetic mechanisms of human disease.
    Brookes E; Shi Y
    Annu Rev Genet; 2014; 48():237-68. PubMed ID: 25195505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic "Drivers" of Cancer.
    Butera A; Melino G; Amelio I
    J Mol Biol; 2021 Jul; 433(15):167094. PubMed ID: 34119490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developmental origins and emerging therapeutic opportunities for childhood cancer.
    Filbin M; Monje M
    Nat Med; 2019 Mar; 25(3):367-376. PubMed ID: 30842674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium signaling and epigenetics: A key point to understand carcinogenesis.
    Izquierdo-Torres E; Hernández-Oliveras A; Fuentes-García G; Zarain-Herzberg Á
    Cell Calcium; 2020 Nov; 91():102285. PubMed ID: 32942140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drosophila as a model for context-dependent tumorigenesis.
    Tipping M; Perrimon N
    J Cell Physiol; 2014 Jan; 229(1):27-33. PubMed ID: 23836429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulated noise in the epigenetic landscape of development and disease.
    Pujadas E; Feinberg AP
    Cell; 2012 Mar; 148(6):1123-31. PubMed ID: 22424224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal order of mutations influences cancer initiation dynamics.
    Teimouri H; Kolomeisky AB
    Phys Biol; 2021 Jul; 18(5):. PubMed ID: 34130273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extrachromosomal DNA (ecDNA) in cancer pathogenesis.
    Wu S; Bafna V; Mischel PS
    Curr Opin Genet Dev; 2021 Feb; 66():78-82. PubMed ID: 33477016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.